Patrick Vermersch
ORCID: 0000-0003-0997-8817Also affiliated with Université de Lille, Centre Hospitalier Universitaire de Lille
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial”.
Douglas L. Arnold, Patrick Vermersch, Amit Bar‐Or, Robert J. Fox, André Palma da Cunha Matta +48 more
Aksel Sıva, Maria Pia Sormani, Cassandre Landes-Château, Lydiane Mondot, Francesca Bovis +72 more
Gloria Dalla Costa, Bruno Stankoff, Hans-Peter Hartung, Per Soelberg Sørensen, Patrick Vermersch +2 more
Peter A. Calabresi, Frederik Barkhof, Ari Green, Randy H. Kardon, Jaume Sastre‐Garriga +10 more
Seyedamirhosein Motamedi, Susanna Asseyer, Claudia Chien, Shiv Saidha, Peter A. Calabresi +29 more